CGTX- Cognition Therapeutics Inc

Name: Cognition Therapeutics Inc Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Cognition Therapeutics Inc (CGTX) has 9 insiders with recent SEC Form 4 filings, including 9 buys and 5 sells. CGTX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Ricciardi Lisa	1.01M	$1.23M	-
Other	Caggiano Anthony	528.3K	$639.2K	-
CFO	Doyle John Brendan	455.4K	$551.0K	-
Dir	Wallace Peggy	86.5K	$104.6K	-
Dir	Richstone Ellen B	58.5K	$70.8K	-

Activity

Buys and sells only

Transactions

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 15, 2022	Wallace Peggy	Director	Buy	12,500	$1.20	$15,000.00	+49.1%	+24.8%	-27.6%
Oct 13, 2021	Golden Seeds Cognition Therapeutics LLC	10% Owner	Sell	33	$12.00	$397.08	-	-43.4%	-85.1%
Oct 13, 2021	Breedlove Mark H.	Director	Sell	12	$12.00	$140.88	-	-43.4%	-85.1%
Oct 13, 2021	Bios Memory Spv I, LP	10% Owner	Sell	90	$12.00	$1,083.36	-	-43.4%	-85.1%
Oct 13, 2021	Fletcher Aaron G.L.50	Director	Sell	90	$12.00	$1,083.36	-	-43.4%	-85.1%
Oct 13, 2021	Ogden Cap Associates, LLC	10% Owner	Sell	74	$12.00	$888.60	-	-43.4%	-85.1%
Oct 13, 2021	Bios Memory Spv I, LP	10% Owner	Buy	190,000	$12.00	$2,280,000.00	+22.2%	-43.4%	-85.1%
Oct 13, 2021	Fletcher Aaron G.L.50	Director	Buy	190,000	$12.00	$2,280,000.00	+22.2%	-43.4%	-85.1%
Oct 13, 2021	Wallace Peggy	Director	Buy	3,000	$12.00	$36,000.00	New	-43.4%	-85.1%
Oct 13, 2021	Ricciardi Lisa	CEO &President	Buy	12,500	$12.00	$150,000.00	New	-43.4%	-85.1%

← PrevPage 2Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC